SEARCH

SEARCH BY CITATION

References

  • 1
    Hindahl CB, Wilson JW. Flash pulmonary oedema during anidulafungin administration. J Clin Pharm Ther, 2012;37:491493.
  • 2
    Fink M, Zerlauth U, Kaulfersch C et al. A severe case of haemodynamic instability during anidulafungin administration. J Clin Pharm Ther, 2013;38:241242.
  • 3
    Lichtenstern C, Wolff M, Arens C et al. Cardiac effects of echinocandin preparations – three case reports. J Clin Pharm Ther, 2013;38:429431.
  • 4
    Stover KR, Farley J, Kyle P, Cleary JD. Cardiotoxicity of some echinocandin antifungals. Expert Opin Drug Saf, 2013; doi:10.1517/14740338.2013.829036. [Epub ahead of print].
  • 5
    Lui P, Ruhnke M, Meersseman W, Paiva JA, Kantecki M, Damle B. Pharmacokinetics of anidulafungin in critically ill patients with candidemia/invasive candidiasis. Antimicrob Agents Chemother, 2013;57:16721676.
  • 6
    Weiler S, Seger C, Pfisterer H et al. Pharmacokinetics of caspofungin in critically ill patients on continuous renal replacement therapy. Antimicrob Agents Chemother, 2013;57:40534057.
  • 7
    Kuse ER, Demeyer I, Undre N. Pharmacokinetics of micafungin in adult patients with invasive candidiasis and candidaemia. OJMM, 2012;2:8490.
  • 8
    Stone JA, Holland SD, Wickersham PJ et al. Single- and multiple-dose pharmacokinetics of caspofungin in healthy men. Antimicrob Agents Chemother, 2002;46:739745.
  • 9
    Pfizer Inc. Eraxis [package insert]. New York, NY: Pfizer Inc., 2006.
  • 10
    Keirns J, Sawamoto T, Holum M, Buell D, Wisemandale W, Alak A. Steady-state pharmacokinetics of micafungin and voriconazole after separate and concomitant dosing in healthy adults. Antimicrob Agents Chemother, 2007;51:787790.
  • 11
    Stover KR, Cleary JD. In vivo evaluation of cardiac toxicity with caspofungin. American College of Clinical Pharmacy 2013 Annual Meeting. Abstract 114. Albuquerque, NM. Pending October 2013.
  • 12
    Stover KR, Hosler JP, Henry GM, Harkins M, Cleary JD. Mitochondrial toxicity with caspofungin. American College of Clinical Pharmacy 2011 Annual Meeting. Abstract 130. Pittsburgh, PA. October 2011.
  • 13
    Stover KR, Hosler JP, Cleary JD. Inhibition of mitochondrial oxidative phosphorylation by anidulafungin. American College of Clinical Pharmacy 2012 Annual Meeting. Abstract 113. Hollywood, FL. October 2012. Encore: UM SOP Research Poster Day. 8 November 2012.
  • 14
    Hosler J, Shapleigh JP. Encyclopedia of environmental microbiology [Internet]. Aerobic Respiration, 1st edn. New York, NY: John Wiley & Sons, Inc, 2003. Available at: http://onlinelibrary.wiley.com/doi/10.1002/0471263397.env158/abstract (accessed 28 October 2013).
  • 15
    Cleary JD, Stover KR, Farley J, Daley W, Kyle PB, Hosler J. Cardiac toxicity of azole antifungals. Pharmacol Pharm, 2013;3:362368.